USFDA Issues Guidance for Impurity Speci
The USFDA has issued a draft guidance for Establishing Impurity Specifications for Antibiotics in April
Warning letters, 483s, Recalls, Import Alerts, Audit observations
The USFDA has issued a draft guidance for Establishing Impurity Specifications for Antibiotics in April
The USFDA has issued a Warning Letter to the Indian drug manufacturing facility of Patcos
FDA issued Warning letter to two Chinese API manufacturers following for cGMP violations including failing